Studies investigating virus-specific IgG and IgM in the acute phase of SARS-CoV-2 infection have found that asymptomatic patients often have weaker immune responses to SARS-CoV-2 and that IgG decreases in the early stage of infection (8). This evidence concerns the gene CD40LG and infection.